1049 related articles for article (PubMed ID: 25913833)
1. Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD).
Nakajima A; Aoyama Y; Shin EJ; Nam Y; Kim HC; Nagai T; Yokosuka A; Mimaki Y; Yokoi T; Ohizumi Y; Yamada K
Behav Brain Res; 2015 Aug; 289():69-77. PubMed ID: 25913833
[TBL] [Abstract][Full Text] [Related]
2. Nobiletin, a citrus flavonoid, ameliorates cognitive impairment, oxidative burden, and hyperphosphorylation of tau in senescence-accelerated mouse.
Nakajima A; Aoyama Y; Nguyen TT; Shin EJ; Kim HC; Yamada S; Nakai T; Nagai T; Yokosuka A; Mimaki Y; Ohizumi Y; Yamada K
Behav Brain Res; 2013 Aug; 250():351-60. PubMed ID: 23714077
[TBL] [Abstract][Full Text] [Related]
3. Nobiletin, a citrus flavonoid, improves memory impairment and Abeta pathology in a transgenic mouse model of Alzheimer's disease.
Onozuka H; Nakajima A; Matsuzaki K; Shin RW; Ogino K; Saigusa D; Tetsu N; Yokosuka A; Sashida Y; Mimaki Y; Yamakuni T; Ohizumi Y
J Pharmacol Exp Ther; 2008 Sep; 326(3):739-44. PubMed ID: 18544674
[TBL] [Abstract][Full Text] [Related]
4. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
5. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
6. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
[TBL] [Abstract][Full Text] [Related]
7. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
8. Nobiletin restoring beta-amyloid-impaired CREB phosphorylation rescues memory deterioration in Alzheimer's disease model rats.
Matsuzaki K; Yamakuni T; Hashimoto M; Haque AM; Shido O; Mimaki Y; Sashida Y; Ohizumi Y
Neurosci Lett; 2006 Jun; 400(3):230-4. PubMed ID: 16581185
[TBL] [Abstract][Full Text] [Related]
9. Traumatic brain injury accelerates amyloid-β deposition and impairs spatial learning in the triple-transgenic mouse model of Alzheimer's disease.
Shishido H; Kishimoto Y; Kawai N; Toyota Y; Ueno M; Kubota T; Kirino Y; Tamiya T
Neurosci Lett; 2016 Aug; 629():62-67. PubMed ID: 27373531
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a 3xTg-AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background.
Virgili J; Lebbadi M; Tremblay C; St-Amour I; Pierrisnard C; Faucher-Genest A; Emond V; Julien C; Calon F
Synapse; 2018 Apr; 72(4):. PubMed ID: 29341269
[TBL] [Abstract][Full Text] [Related]
11. [A new strategy for preventive and functional therapeutic methods for dementia--approach using natural products].
Ohizumi Y
Yakugaku Zasshi; 2015; 135(3):449-64. PubMed ID: 25759053
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
Wu X; Kosaraju J; Zhou W; Tam KY
ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
[TBL] [Abstract][Full Text] [Related]
13. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
Wu X; Kosaraju J; Zhou W; Tam KY
Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
[TBL] [Abstract][Full Text] [Related]
14. Short-term modern life-like stress exacerbates Aβ-pathology and synapse loss in 3xTg-AD mice.
Baglietto-Vargas D; Chen Y; Suh D; Ager RR; Rodriguez-Ortiz CJ; Medeiros R; Myczek K; Green KN; Baram TZ; LaFerla FM
J Neurochem; 2015 Sep; 134(5):915-26. PubMed ID: 26077803
[TBL] [Abstract][Full Text] [Related]
15. Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease.
Zeng Y; Zhang J; Zhu Y; Zhang J; Shen H; Lu J; Pan X; Lin N; Dai X; Zhou M; Chen X
J Neurochem; 2015 Apr; 133(1):38-52. PubMed ID: 25661995
[TBL] [Abstract][Full Text] [Related]
16. Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms.
Giuliani D; Ottani A; Zaffe D; Galantucci M; Strinati F; Lodi R; Guarini S
Neurobiol Learn Mem; 2013 Sep; 104():82-91. PubMed ID: 23726868
[TBL] [Abstract][Full Text] [Related]
17. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
[TBL] [Abstract][Full Text] [Related]
18. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
Huang M; Jiang X; Liang Y; Liu Q; Chen S; Guo Y
Exp Gerontol; 2017 May; 91():25-33. PubMed ID: 28223223
[TBL] [Abstract][Full Text] [Related]
19. Identification of the key molecules involved in chronic copper exposure-aggravated memory impairment in transgenic mice of Alzheimer's disease using proteomic analysis.
Yu J; Luo X; Xu H; Ma Q; Yuan J; Li X; Chang RC; Qu Z; Huang X; Zhuang Z; Liu J; Yang X
J Alzheimers Dis; 2015; 44(2):455-69. PubMed ID: 25352456
[TBL] [Abstract][Full Text] [Related]
20. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
